A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis (Q63576351)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis |
clinical trial |
Statements
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis (English)
0 references
9 May 2017
0 references
22 May 2020
0 references
750
0 references
18 year
0 references